| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2011 | WO2011022509A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022508A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022502A1 Boronic acid compositions and methods related to cancer |
| 02/24/2011 | WO2011022491A1 Cysteine for physiological injection |
| 02/24/2011 | WO2011022489A2 (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders |
| 02/24/2011 | WO2011022473A1 Biaryl compounds and methods of use thereof |
| 02/24/2011 | WO2011022467A2 Controlled-release formulations of anabaseine compounds and uses thereof |
| 02/24/2011 | WO2011022449A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | WO2011022440A2 Heat shock protein binding compounds, compositions, and methods for making and using same |
| 02/24/2011 | WO2011022439A1 Heterocyclic compounds and uses thereof |
| 02/24/2011 | WO2011022393A2 Phosphatidylcholine transfer protein inhibitors |
| 02/24/2011 | WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase |
| 02/24/2011 | WO2011022345A1 Broad spectrum preservation blends |
| 02/24/2011 | WO2011022337A1 Boron-containing small molecules as antiprotozoal agents |
| 02/24/2011 | WO2011022315A1 Pyrazinyl phenyl amide t-type calcium channel antagonists |
| 02/24/2011 | WO2011022292A2 Method of treating bipolar disorder or depression using an antiestrogen |
| 02/24/2011 | WO2011022216A1 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
| 02/24/2011 | WO2011022207A1 Bis-sulfonamide derivatives, compositions, and methods of use |
| 02/24/2011 | WO2011022191A1 Adamantane analogs |
| 02/24/2011 | WO2011022089A1 Imatinib immunoassay |
| 02/24/2011 | WO2011022075A1 Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
| 02/24/2011 | WO2011022074A1 Riboflavin based aerosol and use as placebo in trials |
| 02/24/2011 | WO2011022063A1 Low frequency glatiramer acetate therapy |
| 02/24/2011 | WO2011022028A2 Small molecule antagonists of phosphatidylinositol-3, 4, 5-triphosphate (pip3) and uses thereof |
| 02/24/2011 | WO2011021979A1 Cinnoline compounds, their preparation, and their use |
| 02/24/2011 | WO2011021938A2 Regulating the amino acid pool used for the acute-phase protein synthesis |
| 02/24/2011 | WO2011021926A1 Regulating the amino acid pool used for the acute-phase protein synthesis |
| 02/24/2011 | WO2011021892A2 Composition for skin improvement comprising hexamidines and retinoids |
| 02/24/2011 | WO2011021864A2 Novel compound for complementing anticancer drugs, a production method for the same, a composition for complementing anticancer drugs comprising the same, and a method for reducing resistance to anticancer drugs using the same |
| 02/24/2011 | WO2011021818A2 Composition for proliferating epidermal keratinocyte stem cells |
| 02/24/2011 | WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021597A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | WO2011021508A1 Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c |
| 02/24/2011 | WO2011021397A1 Colchicine derivatives |
| 02/24/2011 | WO2011021212A1 Methods of treating drug resistant and other tumors with 6,7-dialkoxy quinazoline derivatives |
| 02/24/2011 | WO2011021209A1 Histone deacetylase inhibitors |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2011021171A1 Preventing and curing beneficial insect diseases via plant transcribed molecules |
| 02/24/2011 | WO2011021038A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors |
| 02/24/2011 | WO2011021036A1 Polyketides analogues and methods for their production |
| 02/24/2011 | WO2011021000A2 A process for the synthesis of naratriptan |
| 02/24/2011 | WO2011020886A1 Novel quinoline-hepcidine antagonists |
| 02/24/2011 | WO2011020861A1 Heterocyclic oxime compounds |
| 02/24/2011 | WO2011020853A1 Compositions containing mixtures of fermentable fibers |
| 02/24/2011 | WO2011020849A1 Cytohesin inhibitors |
| 02/24/2011 | WO2011020822A1 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof for treating retroviral diseases |
| 02/24/2011 | WO2011020806A1 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives |
| 02/24/2011 | WO2011020790A1 Treatment of patients after stent implantation or balloon dilatation and drug eluting stents |
| 02/24/2011 | WO2011020615A1 Novel fxr (nr1h4 ) binding and activity modulating compounds |
| 02/24/2011 | WO2011020610A1 Drug delivery systems (wafer) for pediatric use |
| 02/24/2011 | WO2011020605A1 Process for the production of coevaporates and complexes comprising voriconazole and cyclodextrin |
| 02/24/2011 | WO2011020294A1 Magnetic nanoparticles having novel core-shell structure and ph responsiveness, and use thereof |
| 02/24/2011 | WO2011020288A1 Substituted hydrazide compounds and application thereof |
| 02/24/2011 | WO2011020198A1 Dna ligands for aflatoxin and zearalenone |
| 02/24/2011 | WO2011020193A1 Renin inhibitors |
| 02/24/2011 | WO2011020189A1 Forms of dexlansoprazole and processes for the preparation thereof |
| 02/24/2011 | WO2011020188A1 Peptide sequences and peptide-mediated sirna delivery |
| 02/24/2011 | WO2011020167A1 Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof |
| 02/24/2011 | WO2011001122A3 Pyrazole derivatives, preparation thereof, and therapeutic use thereof |
| 02/24/2011 | WO2011001113A3 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 02/24/2011 | WO2011000945A3 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 02/24/2011 | WO2010150279A3 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor |
| 02/24/2011 | WO2010149944A8 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |
| 02/24/2011 | WO2010148065A9 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
| 02/24/2011 | WO2010146187A3 Process for the preparation of telmisartan |
| 02/24/2011 | WO2010146062A3 Novel anti-nematode therapies targetting strm-1 |
| 02/24/2011 | WO2010144464A3 Solid dispersions containing an apoptosis-promoting agent |
| 02/24/2011 | WO2010144059A3 Novel uses |
| 02/24/2011 | WO2010137855A9 Multi-layer tablet comprising effervescent layer |
| 02/24/2011 | WO2010132757A3 Antibacterial aminoglycoside analogs |
| 02/24/2011 | WO2010129788A3 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders |
| 02/24/2011 | WO2010129318A3 Topical compositions comprising an alkoxylated diphenylacrylate compound and an organic nonionic emulsifier |
| 02/24/2011 | WO2010128755A3 Composition for preventing or treating hair loss containing threonate as an active ingredient |
| 02/24/2011 | WO2010126260A9 Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients |
| 02/24/2011 | WO2010125462A4 Pentamidine combinations for treating cancer |
| 02/24/2011 | WO2010123999A3 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor |
| 02/24/2011 | WO2010123930A3 Chemosensory receptor ligand-based therapies |
| 02/24/2011 | WO2010123865A3 Two component interactive emulsion product |
| 02/24/2011 | WO2010121675A3 Thiazolyl-benzimidazoles |
| 02/24/2011 | WO2010121133A3 Multimodal imaging of fibrin |
| 02/24/2011 | WO2010121128A3 Compositions and methods for treating or inhibiting liver injury |
| 02/24/2011 | WO2010120368A3 Stabilization of radiopharmaceutical compositions using ascorbic acid |
| 02/24/2011 | WO2010118286A3 Benzimidazole modulators of h1 receptor and/or ns4b protein activity |
| 02/24/2011 | WO2010115124A3 Compositions of cholinesterase inhibitors |
| 02/24/2011 | WO2010111525A3 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 02/24/2011 | WO2010111108A3 Compositions and methods for the treatment of wounds |
| 02/24/2011 | WO2010110923A3 Prophylactic and therapeutic treatment of alzheimer's disease |
| 02/24/2011 | WO2010108052A3 Amide derivatives as neuropeptide y5 receptor ligands |
| 02/24/2011 | WO2010107909A3 Methods and compositions for the detection of cancer |
| 02/24/2011 | WO2010104575A3 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/24/2011 | WO2010104571A3 Treating chronic fatigue syndrome and prolonged qt interval |
| 02/24/2011 | WO2010103545A3 Method of use of vitamin k as energy enhancer in diverse disease states |
| 02/24/2011 | WO2010096719A3 Anticancer and antimicrobial compounds from antarctic extremophilic microorganisms |
| 02/24/2011 | WO2010087980A3 Bicyclic amide derivatives for the treatment of respiratory depression |
| 02/24/2011 | WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/24/2011 | WO2010080769A4 Chemotherapeutic methods and compositions |
| 02/24/2011 | WO2010078900A3 Novel aliphatically substituted pyrazolopyridines, and the use thereof |
| 02/24/2011 | WO2010077663A3 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof |